跳至主要内容
临床试验/NCT01922622
NCT01922622已完成不适用

Determination of the Initial Minimum Effective Dose of 0.5% Bupivacaine With 20mcg of Fentanyl Via a Spinal Catheter for Operative Fixation of Fractured Neck of Femur.

Cork University Hospital1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2013年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
33
试验地点
1
主要终点
Initial MLAD of 0.5% bupivacaine with 20mcg of fentanyl required for a sensory block up to T10 on the side of FNF

研究概览

简要总结

Fractured neck of femur (FNF) is a common cause of admission to hospital in elderly patients with multiple comorbidities. Anaesthetic management of this patient group is extremely challenging.Neuraxial anaesthesia with minimum doses of local anaesthetic agents administered via a spinal catheter leads to better cardiovascular stability.The minimum dose of local anaesthetic with intrathecal fentanyl was not established yet.We propose to study and determine the initial minimum local anaesthetic dose (MLAD) of 0.5% bupivacaine with 20 mcg of fentanyl administered via a spinal catheter to achieve a sensory block up to T10 for the operative fixation of FNF.We will use a previously well established Dixon and Massey "up-and-down method" to calculate initial MLAD in this prospective, observational trial.

Objectives: We would like to determine the initial MLAD of 0.5% bupivacaine with 20mcg of fentanyl administered via a spinal catheter required to achieve a sensory block up to T10 on the side of FNF.

Outcomes

Primary outcome:

  1. Initial MLAD of 0.5% bupivacaine with 20mcg of fentanyl required for a sensory block up to T10 on the side of FNF.

Secondary outcomes: 2. Total dose of 0.5% bupivacaine with 20mcg of fentanyl required for the operative fixation of fractured neck of femur. 3. The effect on haemodynamic variables (blood pressure, heart rate). 4. Incidence of side effects 5. The length of postoperative analgesia (the time from the last dose of local anaesthetic administered intrathecally to VAS>3). 6. The time to first rescue analgesic requirement

Study Design Prospective, observational trial.

Study Size Based on the previously well established Dixon and Massey "up-and-down method"(10), we will recruit patients until a successful spinal block has been achieved in six consecutive patients who received a specific dose. This is the requirement to calculate the initial MLAD.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • fractured neck of femur
  • Above 60 years
  • American Society of Anesthetists(ASA) I to III

排除标准

  • Patient refusal
  • Outside Age Range
  • Contraindications to spinal anaesthesia
  • Head injury or other associated injuries
  • Loss of consciousness and signs of acute coronary syndrome
  • Mini-Mental Score < 25 (Appendix 2)
  • Allergy to bupivacaine, lignocaine or fentanyl

结局指标

主要结局

Initial MLAD of 0.5% bupivacaine with 20mcg of fentanyl required for a sensory block up to T10 on the side of FNF

时间窗: 15min

A blinded observer will assess the dermatome level of sensory blockade with an ice-cold test (ethyl-chloride spray) bilaterally after the injection of the local anaesthetic. Block assessment will be performed every 5min up to 15 min after completion of the initial intrathecal injection. Sensory block up to T10=positive result Sensory block below T10=negative result.

次要结局

  • The effect on haemodynamic variables (blood pressure, heart rate).(Duration of surgery.)
  • Total dose of 0.5% bupivacaine with 20mcg of fentanyl required for the operative fixation of fractured neck of femur(Duration of surgery.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

tomas hitka

Clinical fellow in Regional Anaesthesia

Cork University Hospital

研究点 (1)

Loading locations...

相似试验

已完成
不适用
Study to Determine the Optimal Starting Dose of FSH in a Low- Dose-Stepup RegimeWHO group II ovarian failure (first-grade amenorrhea, oligomenorrhea, or anovulatory cycle), luteal phase insufficiency, or unexplained infertility
JPRN-UMIN000015669Department of Obstetrics and Gynecology,Tokushima University Hospital50
已完成
不适用
A clinical phase I study to define recommended dose of cyclophosphamide in combination with bortezomib and dexamethasone(C-BD) for relapsed and refractory multiple myelomamultiple myeloma
JPRN-UMIN000001347Center for Supporting Hematology-Oncology Trial(C-SHOT)18
招募中
不适用
A study to evaluate the optimal dose of FenuLife® (water soluble fiber) for assessment of its effect on occasional burning sensation and associated complaints1) Occasional burning sensation2) Upper abdomen discomfort3) Regurgitation4) Stomach fullness
DRKS00027126Frutarom Ltd.60
进行中(未招募)
1 期
A dose-finding study of efficacy and safety of F13640 in patients with moderate to severe painful peripheral diabetic polyneuropathy - BEST- Diabetes study (Befiradol Dose-Finding Study in diabetic patients)diabetic peripheral neuropathy
EUCTR2009-012123-28-FRInstitut de Recherche Pierre Fabre550
进行中(未招募)
1 期
A dose-finding study of efficacy and safety of F13640 in patients with moderate to severe painful peripheral diabetic polyneuropathy(Protocol version 03, dated 2010-04-09 and Protocol Amendment PA03 (Local/Substantial) - Slovakia, dated 2010-06-29) - BEST- Diabetes study (Befiradol Dose-Finding Study in diabetic patients)diabetic peripheral neuropathyMedDRA version: 9.1Level: LLTClassification code 10012683Term: Diabetic peripheral neuropathy
EUCTR2009-012123-28-SKInstitut de Recherche Pierre Fabre550